Biobank for stroke and related genetic research
Official title: CUHK Stroke Biobank
Run by Chinese University of Hong Kong · NCT03291392 · Data updated 2026-11-12
This study is collecting blood and tissue samples from patients to help researchers learn more about the genetic causes of stroke and related diseases.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | June 15, 2015 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT03291392 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Chinese adults aged 18 and older who have experienced a stroke or are family members of stroke patients.
✕Probably not a fit
Patients who do not have a history of stroke or related conditions may not benefit from participation in this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a biobank of high-quality samples and associated medical data to facilitate future research on stroke, ischemic diseases, and atherosclerosis. Blood, cerebrospinal fluid, and body tissue will be collected from eligible patients, with a focus on understanding the genetic and biological factors contributing to these conditions. The study will also establish operational infrastructure to manage patient consent, sample collection, and data processing, ultimately supporting various research initiatives aimed at improving prevention and treatment strategies.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of stroke and related conditions, leading to improved prevention and treatment options for patients.
How similar studies have gone: Other studies utilizing biobanks for genetic research in stroke have shown promise, indicating that this approach is both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult equal or more 18 years of age and Chinese ONLY. 2. Stroke patients, their family members, and/or the normal subjects without intracranial stenosis or extracranial stenosis, are eligible to join the study. 3. Subject is willing to have blood taken, cerebral spinal fluid and/or body tissue drawn for storage in the research bank. Exclusion Criteria: * None
Where it's running
-
Chinese University of Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Thomas Wai Hong LEUNG, FRCP — Chinese University of Hong Kong
- Study coordinator: Thomas Wai Hong LEUNG, FRCP
- Email: drtleung@cuhk.edu.hk
- Phone: 852-35053593
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intensive statin therapy for ischemic stroke with intracranial atherosclerotic plaques
This study is testing whether stronger doses of statin medication can help people who have had an ischemic stroke due to plaque buildup in their brain arteries.
-
Paired VNS: How the Brain and Pupils Respond in Stroke Patients
This study tests real-time physiologic responses to paired VNS in adults with chronic motor impairment after ischemic stroke to help tailor dosing.
-
NeuroAiD test in mild to moderate ischemic stroke patients
This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.
-
Using IMPROVE to guide carotid revascularisation decisions
This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.
-
High-intensity interval versus moderate continuous exercise for stroke-related muscle loss
This will test whether high-intensity interval training (HIIT) or moderate-intensity continuous training (MCIT) better helps people 1–6 months after an ischemic stroke who have muscle loss regain muscle mass, strength, walking ability, and quality of life.
-
Test of adding a very low-dose edoxaban to standard antiplatelet therapy to prevent another stroke in adults 75 and older
This trial tests whether adding a tiny amount of edoxaban to aspirin or clopidogrel can better prevent a second stroke in people aged 75+ who recently had an ischemic stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.